Abstract. The cell adhesion protein t~-agglutinin is bound to the outer surface of the Saccharomyces cerevisiae cell wall and mediates cell-cell contact in mating, a-Agglutinin is modified by addition of a glycosyl phosphatidylinositol (GPI) anchor as it traverses the secretory pathway. The presence of a GPI anchor is essential for cross-linking into the wall, but the fatty acid and inositol components of the anchor are lost before cell wall association (Lu, C.-E, J. Kurjan, and P. N. . A pathway for cell wall anchorage of Saccharomyces cerevisiae a-agglutinin. Mol. . Cell wall association of ot-agglutinin was accompanied by an increase in size and a gain in reactivity to antibodies directed against ~l,6-glucan. Several kre mutants, which have defects in synthesis of cell wall/~l,6-glucan, had reduced molecular size of cell wall ot-agglutinin. These findings demonstrate that the cell wall form of oz-agglutinin is covalently associated with/31,6-glucan. The ot-agglutinin biosynthetic precursors did not react with antibody to/~l,6-glucan, and the sizes of these forms were unaffected in kre mutants. A COOHterminal truncated form of a-agglutinin, which is not GPI anchored and is secreted into the medium, did not react with the anti-/31,6-glucan. We propose that extracellular cross-linkage to/31,6-glucan mediates covalent association of a-agglutinin with the cell wall in a manner that is dependent on prior addition of a GPI anchor to ot-agglutinin.
the K1 killer toxin, which binds to cell wall /31,6-glucan (Me, aden et al., 1990; Boone et al., 1990; Roemer and Bussey, 1991; Hill et al., 1992; . krel, kre9, and kre11 mutations reduce the level of alkali-insoluble cell wall/31,6-glucan to 60, 20, and 50%, respectively (Boone et al., 1990; . Smaller sizes of the cell wall /~l,6-glucan polymer are also found in these mutants. A kre6 disruption results in reduced levels of both/~l,3-glucan and /31,6-glucan in the cell wall, but does not affect the size of ~l,6-glucan (Roemer and Bussey, 1991; Roemer et al., 1993 Roemer et al., , 1994 . Disruption of KRE5 reduces/~l,6-glucan content to near zero and compromises growth ability (Meaden et al., 1990) .
The wall mannoproteins are usually of high molecular weight, carrying large amounts of N-and/or O-linked mannosepolysaeeharides (Ballou, 1982 (Ballou, , 1988 Fleet, 1991) . The basis of cell wall association of mannoproteins are not well understood. Some mannoproteins can be extracted from the cell wall by SDS whereas others are extracted only after digestion of the cell wall with 3-glucanase Valentin et al., 1984; De Nobel et al., 1990; Mrsa et al., 1992) . The SDS-extractable mannoproteins appear to be non-covalently associated with the cell wall. 5-Glucanase extractable mannoproteins have been shown to contain glucose residues, and it has been proposed that this class of mannoproteins is cross-linked to the wall #-glucan (Shibata et al., 1983; Pastor et al., 1984; Van Rinsum et al., 1991) . Some wall mannoproteins have covalently associated #l,6-glucan .
a-Agglutinin is a cell surface marmoprotein expressed by ot cells. It binds to a-agglutinin expressed on the surface of a ceils to mediate direct cell-cell contact during the mating process (Cross et al., 1988; Terrance and Lipke, 1981; Lipke and Kurjan, 1992) . Mature ot-agglutinin is cell wall anchored and can only be extracted by #-glucanase treatment (Lasky and Ballou, 1988; Hauser and Tanner, 1989; Schreuder et al., 1993; Lu et al., 1994) . We have previously shown that the ot-agglutinin is synthesized with a glycosyl phosphatidylinositol (GPI) ~ anchor (Wojciechowicz et al., 1993) . GPIlinked biosynthetic precursors have been identified, including a 140-kD ER form and a >300-kD plasma membrane form (Wojciechowicz et al., 1993; Lu et al., 1994) . A soluble >300-kD form, which has characteristics of a periplasmic intermediate between the >300-kD plasma membrane form and the cell wall form, has also been detected (Lu et al., 1994) . A model for GPI anchor-mediated cell wall integration of ot-agglutinin has been proposed based on the structure of GPI anchors. Release from the GPI anchor would produce a periplasmic intermediate which subsequently would be linked to the cell wall glucan via a transglycosylation reaction (De Nobel and Lipke, 1994; Lu et al., 1994) .
To explore the mechanism of the cell wall anchorage of c~-agglutinin, we tested whether this protein is cross-linked to the cell wall #-glucan. We show that the (31,3-glucanaseextractable cell wall form of ot-agglutinin is covalently linked to/~l,6-glucan, but the biosynthetic intermediates are not associated with glucan. The implications of these results for the mechanism of mannoprotein linkage to the cell wall are discussed.
Materials and Methods

Yeast Strains and Plasmids
S. cerevisiae strain W303-1B 15 ) was used to express plasmid pAGt~K which contains the full length c~-agglutinin gena AGod in YEp352 (Wojciechowicz et al., 1993) . Plasmid pAGoda21' was constructed by subcloning the 4.5-kb HindIIIXbaI fragment from plasmid pAGed621* (Wojciechowicz et al., 1993) into YEp352. The agod::LEU2 strain is isogenic to W303-1B and was previously described . LB2134-2B (MATot mnn9 SUC2 real reel gal2 CUP1) was obtained from Yeast Genetics Stock Center. X2180-1A (MATc~ SUC2 real mel gal2 CUP1) was used as the tester a strain in the agglutination assay. The KRE disruption mutants krel::HlS3 (MATcO, kre6::HIS3 (MATcO, krell: :URA3 (MATe0, and their isogenic wild type strain SEY6210 his3 lys2 trpl suc2) were described previously (Boone et al., 1990; Roemer and Bussey, 1991; . The kre::HlS3 and kre9::HlS3 strains (MATt~) were obtained by random sporulation of a KRES/kre5::HIS3 and KRE9/kre9::HIS3 heterozygous diploids, respectively, in the SEY6210 background (Spencer and Spencer, 1988 ).
-1. Abbreviations used in this paper: endo H, endo-N-acetylglucosaminidase; GPI, glycosyl phosphatidylinositol.
Metabolic Labeling of Cells
Labeling with [35S]methionine was performed as described (Lu et al., 1994) . Briefly, exponentially growing cells were collected and resuspended at a density of 7 × 107 cells per ml in sulfate-free medium. TRAN35S -LABEL (ICN Biochemieals, Irvine, CA) was added to 20 t~Ci/ml, and the suspension was incubated for 30 min at 300C. Synthetic a-factor (a gift of Dr. Fred Nalder, College of Staten Island, Staten Island, NY) was added to 50 ng/ml cell suspension 10 rain before labeling. At the end of the labeling the cells were collected and washed as described (Lu et al., 1994) . The medium was processed as described below.
Isolation of Cell Walls and Laminarinase Treatment
Labeled or unlabeled cells were broken with glass beads in 2% SDS lysis buffer containing 50 mM Tris-HC1, pH 7.4, 150 mM NaCl, 5 mM EIXI'A, 1 mM PMSF, 30 ~g/ml each of leupeptin, pepstatin, and antipain, followed by heating at 100°C for 5 rain. The insoluble cell walls were separated from the SDS extract by spinning at 13,600 g for 5 rain, and extracted once with SDS lysis buffer by heating for 5 rain at 100°C. The cell wall pellet was then washed, and treated with laminarinase as described (Lu et al., 1994) .
Isolation of Secreted ~-Agglutinin from the Growth Medium
ago.l::LEU2[pAGu1621'l cells were grown in 300 ml synthetic medium without leucine and uracil at 30"C to stationary phase. The growth medium was separated from the cells and freeze-dried. The dried material was redissolved in 5 ml of 10 mM Tris-HCl, pH 7.4, and dialyzed against 4 liters of 10 mM Tris-HC1, pH 7.4, 1 mM EDTA, and 0.1 mM PMSF overnight at 4°C. For isolating secreted c~-agglutinin from the kre mutants, labeled growth media (8 nal) were dialyzed in the above buffer, and the dialysates were concentrated to 1.6 ml. o~Agglutinln was immunoprecipitated from the concentrated, dialyzed media.
Purification of Anti-fJl,6-Glucan Antibodies
The anti-/~l,6-glucan antiserum was raised against bovine serum albumin-/~l,6-glucan conjugates in rabbit and was purified using affinity chromatography. Epoxy-activated Sepharose 6B (Pharmacia Fine Chemicals, Piscataway, NJ) was used to couple B1,6-glucan via direct coupling of free oxirane groups to the hydroxyl groups of the sugars. 360 nag of pustulan (/31,6-glucan) was dissolved in 21 ml of distilled water by autoclaving for 40 rain at 110*C, and incubated with swollen Sepharose gel (from 3 mg dried beads) at 37"C for 20 h with shaking. After the coupling, excess fll,6-glucan was removed, and the gel was used to pack the column. The antiserum was treated with ammonium sulfate to separate albumins from the immunoglobulins (Harlow and lane, 1988) . The precipitate was redissolved in PBS (Harlow and Lane, 1988) , and applied on the column with a flow rate of 0.5 ml/min. The column was washed with at least 10-bed volumes of PBS. The bound antibodies were eluted with 0.1 M glycine, pH 2.5, and dialyzed against distilled water. The purified antibody solution was concentrated and stored at -20"C.
Immunoprecipitation
c~-Agglutinin was immunoprecipitated from SDS extracts of cells or from laminarinase extracts of the cell walls of 7.5 x 107 plasmid-containing cells or 5 x 108 cells without plasmid as described previously (Lu et al., 1994) . For immunoprecipitating secreted a-agglutinin, concentrated and dialyzed media were adjusted to 1% Triton X-100, 0.1% SDS, 50 mM Tris-HCI (pH 7.4), 150 mM NaCI, 5 mM EDTA, 1 mM PMSF, 30 ~g/ml each of leupeptin, pepstatin, and antipain. To 800 #1 of the material 5 ~1 antic~-agglutinln antiserum (AG3) was added. The antiserum was pre-adsorbed with heat-killed a cells as described . The a-agglutinin immunopreeipitates were analyzed on 6% SDS-polyacrylamide gels, which were processed for fluorography (Lu et al., 1994) or immunoblotting. For fluorography, the gels were soaked in sodium salicylate, dried, and exposed to Kodak X-omat XAR film at -70°C for 2 d. The a-agglutinln from a constant number of ceils was loaded in each lane, except for Fig. 2 , in which a constant amount of radioactivity was loaded.
by boiling at 100°C for 5 rain. 25/zl a-ngglutinin eluate was diluted with endo H buffer (20 mM sodium acetate, pH 5.5, 2 mM EDTA, 1 mM PMSE and 30 ttg/mi each of leupeptin, pepstatin, and antipain) to 100 #1.8 td of recombinant endo N-aeetylglucosaminidase H (endo H; BoehringerMannheim Biochemieals, Indianapolis, IN) (8 mU) was added and the mixture was incubated overnight at 35"C.
Immunoblotting
After separation on SDS-polyacrylamide gels, proteins were transferred to nitrocellulose membranes overnight at 40 V. The membranes were blocked with 3 % gelatin at 30°C for 2 h, and incubated with the purified anti-~,6-glucan antibodies (0.5 ttg//zl) (1:2,500 dilution in PBS containing 0.1% Tweeu-20) for 1 h at room temperature. The blots were then incubated in peroxidase-conjngated anti-rabbit lgG (Sigma Chemical Co., St. Louis, MO) 0:2,500 dilution in PBS containing 0.2% Tween 20) for 45 rain at room temperature. The immuuoblots were visualized with ECL Western blotting detection reagents (Amersham Corp., Arlington Heights, IL) according to the manufacturer's instruction. For antibody competition experiments, pustulan (BI,6-glucan), laminarin (B1,3-gluean), or mannan with a concentration of 1 mM glucose or mannose equivalent was added to the anti-BI,6-glucan solution. The pustelan, laminarin, and mannan were dissolved in PBS by autoclaving at ll0°C for 30 rain.
Results
The Molecular Size of ~-Agglutinin Increases during Covalent Association with the Cell Wall
We have previously identified three forms of ot-agglutinin with molecular sizes >300 kDa: two SDS-soluble forms and a cell wall form. The SDS extracts contain a GPI-anchored form and a form that has lost the fatty acid and inositol moieties from the anchor. These forms are predicted to be intermediates in the cell wall anchorage process (Lu et al., 1994) .
Cell wall ot-agglutinin was isolated from SDS-extracted cell walls by treatment with laminarinase, which contains /31,3-glucanase as the predominant activity ( Fig. 1 A, lane/) (Van Rinsum et al., 1991; Lu et al., 1994) . Laminarinasemediated proteolysis of ~-agglutinin is not detectable under the experimental conditions (Lu et al., 1994) . The >300-kD intermediate forms as well as a 140-kD intracellular form of a-agglutinin were immunoprecipitated from the SDS extract of the cells ( Fig. 1 B , lane/). The apparent molecular sizes of the cell wall form and the SDS-soluble forms have not been determined previously; all three forms migrated near the top of 6% SDS-polyacrylamide gels. However, after treatment with endo H, which removes N-linked saccharides, the large forms that are extracted with SDS were reduced to about 200 kD ( Fig. 1 B, lane 2), whereas the endo H-treated cell wall form showed a molecular weight of 240-300 kD ( mnn9 cells make mannoproteins without outer mannose polysaccharide chains added to the N-linked core saccharides (Tsai et ai., 1984; Tanner and Lehle, 1987) . In an mnn9 mutant, an increase in molecular size of the cell wall form of ~x-agglutinin relative to precursors was seen even in the absence of endo H treatment (Fig. 1) . The SDS extract of the mnn9 cells contained forms of ot-agglutinin with molecular weights of 140 and 225 kD ( Fig. 1 B, lane 3) . The size of the 140-kD form, which occurs in the ER (Lu et al., 1994), was not affected by the mnn9 mutation. In accordance with onine and broken in SDS lysis buffer, a-Agglutinin was immunoprecipitated from the SDS extracts of the cells and from the laminarinase extracts of the cell walls using anti-a-agglutinin antiserum, and analyzed by SDS-polyacrylamide gel electrophoresis and fluorography, (A) Laminarinase-extracted cell wall form of ot-agglutinin. (B) SDS-extracted forms of ot-agglutinin (biosynthetic intermediates; Lu et al., 1994) . The >300-kD a-agglutinin contains a soluble >300 form and a membrane-bound >300-kD form (Lu et al., 1994) . The molecular size standards on the right are labeled in kD.
the mnn9 phenotype, the molecular size of the 225-kD form from mnn9 cells was close to that of the de-N-glycosylated soluble large forms of ot-agglutinin (200 kD). The cell wall form of t~-agglutinin from mnn9 cells, although migrating faster than the cell wall form from wild type cells, had apparent molecular size of>250 kD ( Fig. 1 A, lane 3) . The apparent higher molecular size of the cell wall form (>250 kD) compared to the SDS-extractable 225-kD o~-agglutinin in mnn9 cells again indicated that the a-agglutinin was modified before or during anchorage in the cell wall.
kre Mutations Affect Cell Wall Anchorage and Molecular Size of Cell Wall ~-Agglutinin
Some/31,3-glucanase-extractable cell wall proteins are covalently linked to/$1,6-glucans . We speculated that the cell wall anchorage of ot-agglutinin resulted from a covalent linkage to the wall fll,6-glucan which was in turn cross-linked to other cell wall components. Therefore, krel, kreS, kre6, kre9, and krell gene disruption mutants, which have defects in synthesis of/~l,6-glucan, were tested for effects on ot-agglutinin.
Assays for functional cell surface o~-agglutinin revealed no significant decrease in the agglutinability of the krel::HIS3 and kre11::URA3 mutants relative to the isogenic wild-type strain (Table I ). This result indicated that ot-agglutinin is expressed on the cell surface of krel::HIS3 and krell::URA3 mutants. Since the kre5::HIS3 and kret: :HIS3 mutant cells are abnormally large and the kre9::HIS3 cells formed aggregates, the agglutinability of these two mutants was difficult to quantify using our assay, which measures the optical density of the cell suspension after the aggregates are sedimented (Terrance and Lipke, 1981) . However, when kre6:: HIS3 or kre9::HIS3 mutant cells were mixed with tester a cells, larger aggregates were formed, indicating that these mutant cells are agglutinable.
We next tested the effect of KRE gene disruptions on ot-agglutinin secretion. Wild type strain SEY6210 secreted a small amount of ot-agglutinin into the medium. The secreted o~-agglutinin had molecular size >300 kD, which was reduced to 200 kD after endo H treatment (data not shown). The kre mutants secreted more ct-agglutinin into the growth medium than the wild-type strain. The fraction of the secreted ot-agglutinin to the laminarinase-extracted cell wall ct-agglutinin increased two-to threefold in the krel::HIS3, kre6: :HIS3, kreg: :HIS3, and kre11: : URA3 mutants (Table I) .
kre5 mutants show a severe deficiency in B1,6-glucan syn- * AI, agglutination index. Higher AI indicates a greater degree of agglutination. The agglutination assay was performed as described previously (Terrance and Lipke, 1991) . The tester a cells (X2180-1A) were pretreated with a-factor as described (Terrance and Lipke, 1981) . ND, not determined. ~; The kre mutants and their isogenic wild type swain (KRE) were metabolically labeled with [35S]methionine for 30 min and separated from the media. The cell wall ct-agglutinin was solubilized from SDS-extracted cell walls by treatment with laminarinase, and subsequently immunoprecipitated. Under the experimental conditions, half of the total amount of the cell wall a-agglntinin was extracted from the mutant and the wild type cell walls, as determined by time courses of release of a-agglutinin. The secreted a-agglutinin was immunoprecipitated from the labeling media. The a-agglntinin precipitates were subjected to SDS-polyacrylamide gel dectrophorresis followed by fluorography. ot-Agglntinin bands were excised from the gel and quantitated by liquid scintillation counting. The fraction of secreted o¢-agglutinin was defined as the radioactivity of ct-agglutinin in the culture medium divided by the sum of the ot-agglutinin radioactivity in the medium and that extracted from cell walls. Cell wall a-agglutinin radioactivity was corrected for the efficiency of extraction from the cell wall.
thesis, a growth defect, and aberrant morphology (Meaden et al., 1990) . Two kre5::HIS3 MATer strains were obtained by sporulation of a heterozygous diploid. These strains secreted the majority of their ot-agglutinln into the growth medium (Table I) . Analysis of the cell walls showed <10% of wild type levels of ot-agglutinin in the walls (data not shown). Thus, the severe defect in glucan synthesis in the kre5::HIS3 strains was accompanied by a failure to anchor most of the ot-agglutinin into the ceil wall. The ot-agglutinin secreted from the kre mutants exhibited no mobility difference from that secreted from the wild type cells (data not shown). Despite the increased secretion, a substantial amount of a-agglutinin in kre mutants (other than kre5::HIS3) remained associated with the cell wall, and could only be released by laminarinase treatment, suggesting that the majority of the ot-agglutinln produced in the krel:: HIS3, kre6". :HIS3, kre9::HIS& and krell:: URA3 mutants is anchored in the cell wall.
The increase in ct-agglutinin secretion could be a general effect of kre mutations on cell wall structure. A krel mutant oversecretes proteins normally found in the growth medium (Bussey et al., 1983) , and analysis of the proteins in the culture supernatant from wild type and krel cells showed increased levels of at least seven other proteins in the krel null mutant compared to the wild type strain (data not shown).
To determine whether anchorage of ot-agglutinin was specifically affected by the kre mutations, we assayed the molecular size of the ot-aggutinin from the cell walls of the mutants. Before endo H treatment, the laminarinase-extracted cell wall form of t~-agglutinin from the mutants and from the wild type strain migrated on the top of 6% SDS-polyacrylam/de gels, and the molecular sizes could not be compared. After endo H treatment, the cell wall ot-agglutinln from krel::HIS3 and kre9::HIS3 mutants showed molecular sizes of 200-240 and 200-270 kD, respectively, significantly smaller than that from the isogenic wild type strain (Fig. 2  A) . A slight size reduction of the cell wall ot-agglutinin was observed in kre6::HIS3 and krell::URA3 mutants (Fig. 2 A) . This reduction was observed in several preparations of cell wall ot-agglutinin from these mutants. A small amount of endo H resistant material was seen in extracts from all kre mutants. It is not clear whether this material represents an endo H-resistant form of ct-agglutinin or non-glycosylated proteins that remain associated with ot-agglutinin during immunoprecipitation.
The altered cell wall structure of the krel mutant is likely to make the cell wall glucans more accessible to added enzymes; therefore the reduced molecular size of the cell wall a-agglutinin from the krel: :HIS3 mutant could have resulted from more extensive digestion by laminarinase during the extraction from the cell wall (Boone et ai., 1990) . To address this possibility, time courses of laminarinase digestion were performed. Cell walls from krel::HIS3 cells were treated with laminarinase for various periods of time from 1-16 h. The extracted cell wall ot-agglutinin, after endo H treatment, showed no mobility difference over the time course (Fig. 2  B) . We also monitored laminafina~ digestion of ct-agglutinln isolated from wild type cells. The cell wall ct-agglutinln was solubilized from the wild type cell wall in an initial 2-h incubation, and then was reincubated in the presence of laminarinase to examine whether extended laminarinase digestion would further reduce the size of the wild type cell wall ot-agglutinin. A 16-h incubation with laminarinase yielded t~-agglutinin of the same molecular size as that originally isolated (Fig. 2 B) . These results imply that the lower molecular size of the cell wall a-agglutinin in the krel::HIS3 mutant relative to wild type is not due to incomplete laminarinase digestion during the extraction from the wall of wild type cells.
The molecular sizes of the non-cell wall intermediates of ot-agglutinin were unaffected by kre disruptions. The SDSextracted >300-kD ot-agglutinln from the wild type and mutant strains had an apparent molecular size of 200 kD after endo H treatment (Fig. 2 C) . To further test whether the krel::HIS3 mutation affects only cell wall proteins, the plasma membrane-bound GPI-anchored glycoprotein Gaslp or Ggplp was immunoprecipitated from the membrane fractions (Nuoffer et al., 1991; Vai et al., 1990; Fankhauser and Conzelmann, 1991) . Gaslp from the krel mutant and from the wild-type strain exhibited no mobility difference (data not shown). Therefore the krel::HIS3 mutation altered processing of cell wall-associated c~-agglutinin, but did not affect processing of a membrane-associated GPI-anchored glycoprotein.
Cell Wall a-Agglutinin Is Immunoreactive with Anti-Bl,6-Glucan Antibodies
The possibility that the cell wall c~-agglutinin was covalently linked to cell wall/~-glucan was further tested using specific anti-/~l,6-glucan antibodies. The antibodies were raised against/31,6-glucan serum albumin conjugate and purified using a/~l,6-glucan affinity column. Cell wall a-agglutinin was immunoprecipitated from the laminarinase extract of the cell wall with anti-c~-agglutinin antibodies, and the precipitate was analyzed by immunoblotting with anti-/3'l,6-glucan antibodies. The cell wall form of ct-agglutinin was recognized by the anti-/5'l,6-glucan antibodies both before and after treatment with endo H (Fig. 3 B,  lanes 1 and 2) . This recognition was competitively inhibited by pustulan (~l,6-glucan) (Fig. 3 C, lanes 1 and 2) , but not by laminarin (/~l,3-glucan) or mannan (data not shown). These results indicate that the epitope on the cell wall ot-agglutinin consists of ~l,6-glucan. Cell wall ct-agglutinin from the krel::HIS3 cells was less reactive with the anti-15'l,6-glucan antibodies than that from the isogenic wild type strain (Fig. 4) , consistent with a reduced size of/~l,6-glucan in the mutant.
To determine whether the non-cell wall forms of t~-agglutinin contained /$1,6-glucan, the soluble precursors were precipitated from the SDS extract of wild type cells with anti-c~-aggutinin, and immunoblotted with anti-~,6-glucan antibodies. The 140 kD and the >300-kD forms, as well as their corresponding endo H-treated forms, did not react with the ffl,6-glucan antibodies (Fig. 3 B, lanes 3 and 4) , whereas they were strongly stained when reprobed with the a-agglutinin antibodies (Fig. 3 A, lanes 3 and 4) . A weak, immunoreactive band migrated on the very top of the gel (Fig.  3 B, lane 3) . However, this band is non-specific, because it was not competed by 131,6-glucan (Fig. 3 C, lane 3) , did not comigrate with the >300-kD ot-agglutinin band, and was also seen in an a cell extract which does not contain a-agglutinin (data not shown). Because the SDS extracts contain two >300-kD forms of ot-agglutinin, the cells were lysed and fractionated into membrane and soluble protein fractions by ultracentrifugation, which separates the soluble periplasmic >300-kD form from the plasma membranebound >300-kD form (Lu et al., 1994) . Neither >300-kD form was reactive with the anti-/31,6-glucan (data not shown). These results indicate that the addition of/31,6-glucan occurs at the cell surface after formation of the soluble >300-kD form of c~-agglutinin.
A truncation of the COOH-terminal 29-arnino acid residues from Agedp (Agod62~p) eliminates cell surface attach- Figure 4 . Effect of krel gene disruption on immunoreaetivity of the cell wall ct-agglutinin with anti-/~l,6-glucan. The kre/mutant and its isogenic wild-type strain (KRE) were lysed in SDS lysis buffer, and the cell walls were collected and treated with laminarinase. The wall c~-agglutinin was immunoprecipitated with anti-t~-agglutinin, separated on SDS-polyacrylamide gels, and blotted onto nitrocellulose membranes. The blots were probed with anti-ct-agglutinin (A) or anti-/31,6-glucan (B). Equal amounts of samples were loaded in the corresponding lanes in A and B. ment and allows secretion of active ot-agglutinin into the medium (Wojciechowicz et al., 1993) . The loss of cell surface attachment in the Agot162~p apparently results from a defect in GPI anchor addition (Wojciechowicz et al., 1993) . We therefore determined whether the AC_md~l gene product was modified by addition of/31,6-glucan. Agct162tp was precipitated with anti-ct-agglutinin from the growth medium of an agt~l::LEU2[pAGcd62tq strain. Agot162~p exhibited a mobility similar to that of the SDS-extracted >300-kD c~-agglutinin from wild-type ceils (Fig. 3 A, lane 5) . After endo H treatment, the size of the Ag~162tp shifted to 200 kD (Fig. 3 A, lane 6) . Aga1621p did not react with the anti-/31,6-glucan, either before or after endo H treatment (Fig. 3 B, lanes 5 and 6) . A very weak, /31,6-glucan noncompetitive signal was seen at the top of the gel (Fig. 3, B and C, lane 5). This signal was non-specific, as it was also found in the growth medium of agal::LEU2 cells without pAGed6z~' (data not shown). This result suggests that the GPI anchor is necessary for cross-linkage of the cell wall oL-agglutinin and the/~l,6-glucan.
Discussion
Three extracellular forms of ot-agglutinin have been identiffed: a GPI-anchored form bound to the plasma membrane, a soluble periplasmic form which has lost the fatty acid and inositol from the GPI anchor, and the mature form that is covalenfly bound to the cell wall (Lu et ai., 1994) . We have proposed that the plasma membrane form is released to produce the periplasmic form, which then becomes linked to the cell wall. To examine the mechanism of cell wall attachment, we have further characterized these forms, which were previously indistinguishable in SDS gel analysis due to their large size (>300 kD). After endo H treatment to release N-linked carbohydrate, the cell wall form had a higher molecular size than the plasma membrane-bound and periplasmic forms. In mnn9 cells, which are defective in addition of outer chain N-linked carbohydrate, a similar molecular size difference was detected even in the absence of endo H treatment. This size difference indicates that covalent modification of ot-agglutinln occurs either immediately before or during cell wall attachment.
Two approaches demonstrated that a-agglutinin is covalenfly modified by addition of/S1,6 glucan in the process of cell wall anchorage. /s1,6-glucan-specific antibodies specifically reacted with cell wall tx-agglutinin but not with the plasma membrane or periplasmic forms of tx-agglutinin. ot-agglutinin was also characterized in kre mutants, which are altered in/s1,6-glucan structure and/or levels in the cell wall. Mutations in krel and kre9 affect late steps in synthesis of cell wall/S1,6 glucan, and show a reduced size and altered structure (Boone et al., 1990; . In these mutants, cell wall a-agglutinin had markedly reduced size after endo H treatment (200-240 and 200-270 kD for krel and kre9, respectively, versus 240-300 kD for the wildtype). Cell wall ct-agglutinln from krel cells was less reactive with anti-B1,6-glucan antibodies in comparison to the wildtype, consistent with the shorter/s1,6-glucan polymers found in krel mutants.
In addition to the alterations in/s1,6-glucan structure discussed above, krel, kre5, kre6, kre9, and krell mutants show reduced amounts of cell wall /s1,6-glucan . The tested kre mutants showed increased secretion of ct-agglutinin with a concomitant reduction in the fraction of c~-agglutinin bound to the cell wall. The increase in secretion of tx-agglutinin was most marked in the strain with the most severe phenotype.
Covalent association of tx-agglutinin with/s1,6-glucan would provide a mechanism to anchor the glycoprotein to the cell wall matrix. The bonds created during the association of ct-agglutinin or other mannoproteins with cell wall glucan are not known, but the structures of the components suggest several possibilities. Ghican could be attached to tx-agglutinin through N-or O-linkage or through linkage to the GPI anchor.
Several lines of evidence argue against N-or O-linkage of the glucan to the peptide. Endo H-treated cell wall tx-agglutinln remained reactive with the anti-BI,6-glucan antibodies; therefore the/s1,6-glucan is not attached to endo H-sensitive N-linked chains. Anchorage of tx-agglutinin and bulk mannoproteins is not affected in a rann9 mutant, which has severely truncated mannosyl side chains, or by tunicamycin treatment (Wojciechowicz et ai., 1993; Lu et al., 1994) . In addition, the a-agglutinin anchorage subunit Agaip contains no consensus N-glycosylation sites and appears to contain only O-linked carbohydrate mannosyl chains (Lipke and Kurjan, 1992) ; therefore unless a-and c~-agglutinins use different mechanisms of cell wall attachment, linkage cannot be through a conventional N-linked carbohydrate chain. Attachment through O-linked carbohydrate is not consistent with the alkali resistance of the/s-glucan association with mannoprotein (Van Rinsum et al., 1991) .
Recently, Schreiner et al. (1994) have reported a direct linkage of/s-glucose to asparagine in mammalian laminin. A similar linkage in tx-agglutinin would be resistant to endo H and to tunicamycin, and S ° cannot be ruled out. However, it is not apparent how formation of such a linkage would be dependent on GPI anchor addition in c~-agglutinin.
The current results are consistent with/s1,6-glucan attachment to a modified GPI anchor. A COOH-terminal truncation of ot-agglutinln that eliminates GPI anchor attachment results in secretion of tx-agglutinln into the medium (Wojciechowicz et al., 1993) and a lack of recognition by anti-/51,6-glucan antibodies (Fig. 3 A) . The periplasmic form of ot-agghitinin lacks the inositol and fatty acid components of the GPI anchor but preliminary results indicate that at least the ethanolamine moiety of the GPI anchor remains (Lu, C. E, and P. N. Lipke, unpublished results). Removal of the phosphatidylinositol component of the GPI anchor would leave the COOH-terminal glycan attached to the protein, including ethanolamine phosphate and at least one carbohydrate residue (De Nobel and Lipke, 1994) . The reducing end of the GPI-derived glycan would remain with the protein and could become attached to cell wall/s1,6-glucan by a transglycosylation reaction (De Nobel and Lipke, 1994) . The structure of Candida albicans mannoproteins is consistent with this hypothesis;/s1,6-glucan linkage to marmoproteins is through a phosphodiester linkage (Kapteyn et al., 1994) , as is the linkage between GPI anchors and proteins. Further support for this hypothesis comes from construction of chimeric proteins (Van Berkel et al., 1994) . Addition of the COOH-terminal 30-amino acid residues of c~-agglutinin to the secreted marker protein ct-galactosidase is sufficient to /s-glucosylate and anchor the tx-galactosidase in the cell wall of S. cerevisiae. This 30-residue ct-agglutinin sequence contalns the GPI addition signal, but only a few potential O-glycosylation sites, and no Asn residues.
Processing and assembly of ct-agglutinin and/s1,6-glucan are complex processes. The cellular locations of the products of KRE and related genes imply that/$1,6 glucan assembly is initiated in the ER and proceeds during transport through the secretory pathway ). Krelp appears to be a GPI anchored extracellular protein; therefore final assembly of the glucan may be extracellular, ot-Agghitinin is also synthesized in the ER and altered by GPI addition and • N-and O-glycosylation in the secretory pathway (Lu et al., 1994) . A GPI-anchored form of tx-agglutinin of >300 kD is membrane associated and extracellular (Lu et al., 1994) . Neither this GPI-anchored ot-agglutinin form nor the periplasmic form reacted with anti-BI,6-glucan antibodies and neither form showed size alterations in kre mutants ( Figs. 1  and 2 ). Therefore these forms were not modified by glucan addition, although glucan is covalently bound to the mature cell wall form. We propose that the periplasmic form of c~-agglutinin, and possibly other cell wall mannoproteins, is cross-linked to preformed #l,6-glycan, perhaps by transglycosylation of the GPI anchor-derived glycan, and then becomes integrated into the growing cell wall by linkage of /31,6-glucan to ~l,3-glucan polymers. The data we have presented suggests that the cross-linking reactions are extracellular, and occur within the periplasmic space and cell wall.
